-
公开(公告)号:US20220282221A1
公开(公告)日:2022-09-08
申请号:US17678485
申请日:2022-02-23
发明人: S. Jordan Kerns , Norman Wen , Carol Lucchesi , Christopher David Hinojosa , Jacob Fraser , Jefferson Puerta , Geraldine Hamilton , Robert Barrett , Clive Svendsen , Daniel Levner , Stephen R. Targan , Michael Workman , Dhruv Sareen , Uthra Rajamani , Magdalena Kasendra
摘要: Organs-on-chips are microfluidic devices for culturing living cells in micrometer sized chambers in order to model physiological functions of tissues and organs. Engineered patterning and continuous fluid flow in these devices has allowed culturing of intestinal cells bearing physiologically relevant features and sustained exposure to bacteria while maintaining cellular viability, thereby allowing study of inflammatory bowl diseases. However, existing intestinal cells do not possess all physiologically relevant subtypes, do not possess the repertoire of genetic variations, or allow for study of other important cellular actors such as immune cells. Use of iPSC-derived epithelium, including IBD patient-specific cells, allows for superior disease modeling by capturing the multi-faceted nature of the disease.
-
公开(公告)号:US11952592B2
公开(公告)日:2024-04-09
申请号:US17678485
申请日:2022-02-23
发明人: S. Jordan Kerns , Norman Wen , Carol Lucchesi , Christopher David Hinojosa , Jacob Fraser , Jefferson Puerta , Geraldine Hamilton , Robert Barrett , Clive Svendsen , Daniel Levner , Stephen R Targan , Michael Workman , Dhruv Sareen , Uthra Rajamani , Magdalena Kasendra
CPC分类号: C12N5/0679 , C12M21/08 , C12M23/16 , C12N5/0618 , C12N5/0696 , G01N33/5005 , C12N2501/11 , C12N2501/119 , C12N2501/13 , C12N2501/155 , C12N2501/16 , C12N2501/24 , C12N2501/25 , C12N2501/415 , C12N2501/998 , C12N2501/999 , C12N2506/45 , C12N2535/00
摘要: Organs-on-chips are microfluidic devices for culturing living cells in micrometer sized chambers in order to model physiological functions of tissues and organs. Engineered patterning and continuous fluid flow in these devices has allowed culturing of intestinal cells bearing physiologically relevant features and sustained exposure to bacteria while maintaining cellular viability, thereby allowing study of inflammatory bowl diseases. However, existing intestinal cells do not possess all physiologically relevant subtypes, do not possess the repertoire of genetic variations, or allow for study of other important cellular actors such as immune cells. Use of iPSC-derived epithelium, including IBD patient-specific cells, allows for superior disease modeling by capturing the multi-faceted nature of the disease.
-
公开(公告)号:US20240254449A1
公开(公告)日:2024-08-01
申请号:US18626855
申请日:2024-04-04
发明人: S. Jordan Kerns , Norman Wen , Carol Lucchesi , Christopher David Hinojosa , Jacob Fraser , Jefferson Puerta , Geraldine Hamilton , Robert Barrett , Clive Svendsen , Daniel Levner , Stephen R. Targan , Michael Workman , Dhruv Sareen , Uthra Rajamani , Magdalena Kasendra
CPC分类号: C12N5/0679 , C12M21/08 , C12M23/16 , C12N5/0618 , C12N5/0696 , G01N33/5005 , C12N2501/11 , C12N2501/119 , C12N2501/13 , C12N2501/155 , C12N2501/16 , C12N2501/24 , C12N2501/25 , C12N2501/415 , C12N2501/998 , C12N2501/999 , C12N2506/45 , C12N2535/00
摘要: Organs-on-chips are microfluidic devices for culturing living cells in micrometer sized chambers in order to model physiological functions of tissues and organs. Engineered patterning and continuous fluid flow in these devices has allowed culturing of intestinal cells bearing physiologically relevant features and sustained exposure to bacteria while maintaining cellular viability, thereby allowing study of inflammatory bowl diseases. However, existing intestinal cells do not possess all physiologically relevant subtypes, do not possess the repertoire of genetic variations, or allow for study of other important cellular actors such as immune cells. Use of iPSC-derived epithelium, including IBD patient-specific cells, allows for superior disease modeling by capturing the multi-faceted nature of the disease.
-
公开(公告)号:US11326149B2
公开(公告)日:2022-05-10
申请号:US16051004
申请日:2018-07-31
发明人: S. Jordan Kerns , Norman Wen , Carol Lucchesi , Christopher David Hinojosa , Jacob Fraser , Jefferson Puerta , Geraldine Hamilton , Robert Barrett , Clive Svendsen , Daniel Levner , Stephen R Targan , Michael Workman , Dhruv Sareen , Uthra Rajamani , Magdalena Kasendra
摘要: Organs-on-chips are microfluidic devices for culturing living cells in micrometer sized chambers in order to model physiological functions of tissues and organs. Engineered patterning and continuous fluid flow in these devices has allowed culturing of intestinal cells bearing physiologically relevant features and sustained exposure to bacteria while maintaining cellular viability, thereby allowing study of inflammatory bowl diseases. However, existing intestinal cells do not possess all physiologically relevant subtypes, do not possess the repertoire of genetic variations, or allow for study of other important cellular actors such as immune cells. Use of iPSC-derived epithelium, including IBD patient-specific cells, allows for superior disease modeling by capturing the multi-faceted nature of the disease.
-
公开(公告)号:US20190031992A1
公开(公告)日:2019-01-31
申请号:US16051004
申请日:2018-07-31
发明人: S. Jordan Kerns , Norman Wen , Carol Lucchesi , Christopher David Hinojosa , Jacob Fraser , Jefferson Puerta , Geraldine Hamilton , Robert Barrett , Clive Svendsen , Daniel Levner , Stephen R. Targan , Michael Workman , Dhruv Sareen , Uthra Rajamani , Magdalena Kasendra
摘要: Organs-on-chips are microfluidic devices for culturing living cells in micrometer sized chambers in order to model physiological functions of tissues and organs. Engineered patterning and continuous fluid flow in these devices has allowed culturing of intestinal cells bearing physiologically relevant features and sustained exposure to bacteria while maintaining cellular viability, thereby allowing study of inflammatory bowl diseases. However, existing intestinal cells do not possess all physiologically relevant subtypes, do not possess the repertoire of genetic variations, or allow for study of other important cellular actors such as immune cells. Use of iPSC-derived epithelium, including IBD patient-specific cells, allows for superior disease modeling by capturing the multi-faceted nature of the disease.
-
公开(公告)号:US20180057788A1
公开(公告)日:2018-03-01
申请号:US15352289
申请日:2016-11-15
发明人: Jordan Kerns , Norman Wen , Carol Lucchesi , Christopher Hinojosa , Jacob Fraser , Geraldine Hamilton , Gad Vatine , Sam Sances , Clive Svendsen , Daniel Levner , Dhruv Sareen
IPC分类号: C12N5/00 , C12N5/0797 , B01L3/00
CPC分类号: C12N5/0068 , B01L3/502715 , B01L2300/044 , B01L2300/0858 , B01L2300/123 , C12M23/16 , C12M25/02 , C12N5/0623 , C12N5/069 , C12N2502/088 , C12N2531/00 , C12N2535/10 , C12N2539/00
摘要: The invention relates to culturing brain endothelial cells, and optionally astrocytes and neurons in a fluidic device under conditions whereby the cells mimic the structure and function of the blood brain barrier. Culture of such cells in a microfluidic device, whether alone or in combination with other cells, drives maturation and/or differentiation further than existing systems.
-
公开(公告)号:US20210214670A1
公开(公告)日:2021-07-15
申请号:US17160617
申请日:2021-01-28
申请人: Emulate, Inc.
发明人: Daniel Levner , Christopher David Hinojosa , Norman Wen , Antonio Varone , Justin Nguyen , Lina Williamson , S. Jordan Kerns , Catherine Karalis , Geraldine Hamilton , Carol Lucchesi
IPC分类号: C12M1/42 , C12M3/06 , C12M1/12 , G01N33/50 , G01N33/543 , C12M1/00 , C12N5/0793 , C12N5/079 , C12N5/071 , C12N5/077
摘要: A microfluidic device is contemplated comprising an open-top cavity with structural anchors on the vertical wall surfaces that serve to prevent gel shrinkage-induced delamination, a porous membrane (optionally stretchable) positioned in the middle over a microfluidic channel(s). The device is particularly suited to the growth of cells mimicking dermal layers.
-
公开(公告)号:US20180320125A1
公开(公告)日:2018-11-08
申请号:US15781370
申请日:2016-12-02
申请人: EMULATE, INC.
发明人: Daniel Levner , Christopher David Hinojosa , Norman Wen , Antonio Varone , Justin Nguyen , Lina Williamson , S. Jordan Kerns , Katia Karalis , Geraldine Hamilton , Carol Lucchesi
IPC分类号: C12M1/42 , C12M1/12 , C12M3/06 , C12N5/071 , C12N5/077 , C12M1/00 , C12N5/0793 , C12N5/079 , G01N33/50
CPC分类号: C12M35/04 , C12M23/16 , C12M23/38 , C12M25/02 , C12M35/08 , C12N5/0619 , C12N5/0622 , C12N5/0629 , C12N5/0656 , C12N5/0688 , C12N5/069 , C12N5/0697 , C12N5/0698 , C12N2501/165 , G01N33/50 , G01N33/5082 , G01N33/54366
摘要: A microfluidic device is contemplated comprising an open-top cavity with structural anchors on the vertical wall surfaces that serve to prevent gel shrinkage-induced delamination, a porous membrane (optionally stretchable) positioned in the middle over a microfluidic channel(s). The device is particularly suited to the growth of cells mimicking dermal layers.
-
公开(公告)号:US20220033757A1
公开(公告)日:2022-02-03
申请号:US17494221
申请日:2021-10-05
申请人: EMULATE, INC.
发明人: Daniel Levner , Christopher David Hinojosa , Norman Wen , Antonio Varone , Justin Nguyen , Lina Williamson , S. Jordan Kerns , Catherine Karalis , Geraldine Hamilton , Carol Lucchesi
IPC分类号: C12M1/42 , C12M3/06 , C12M1/12 , G01N33/50 , G01N33/543 , C12M1/00 , C12N5/0793 , C12N5/079 , C12N5/071 , C12N5/077
摘要: A microfluidic device is contemplated comprising an open-top cavity with structural anchors on the vertical wall surfaces that serve to prevent gel shrinkage-induced delamination, a porous membrane (optionally stretchable) positioned in the middle over a microfluidic channel(s). The device is particularly suited to the growth of cells mimicking dermal layers.
-
公开(公告)号:US11248203B2
公开(公告)日:2022-02-15
申请号:US17160617
申请日:2021-01-28
申请人: EMULATE, INC.
发明人: Daniel Levner , Christopher David Hinojosa , Norman Wen , Antonio Varone , Justin Nguyen , Lina Williamson , S. Jordan Kerns , Catherine Karalis , Geraldine Hamilton , Carol Lucchesi
IPC分类号: C12M3/06 , C12M1/12 , C12M1/00 , C12M1/42 , G01N33/50 , G01N33/543 , C12N5/0793 , C12N5/079 , C12N5/071 , C12N5/077
摘要: A microfluidic device is contemplated comprising an open-top cavity with structural anchors on the vertical wall surfaces that serve to prevent gel shrinkage-induced delamination, a porous membrane (optionally stretchable) positioned in the middle over a microfluidic channel(s). The device is particularly suited to the growth of cells mimicking dermal layers.
-
-
-
-
-
-
-
-
-